Displaying results 1 - 1 of 1
-
Utilizing the 'Crowd Trial' for Pharmacovigilance: a case report
Content Type: Abstract
Singulair (MONTELUKAST SODIUM) is a Leukotriene receptor antagonist, indicated to prevent asthma attacks in adults and children. It is also used to relieve allergies in adults and children. Singulair was approved by the FDA in February 20, 1998. In… read more